Confirmed Exhibitors and Sponsors
ABBOTTFor over 130 years, Abbott has been committed to helping people live their best possible life through the power of health. Abbott’s broad portfolio of science-based nutrition products nourish at every stage of life. Our research is focused on specific health areas, such as the prevention and management of muscle mass loss through specialized nutrition. The Abbott Nutrition Health Institute (ANHI) connects and empowers people through science-based nutrition resources to optimize health worldwide. ANHI presents the latest science by partnering with leading nutrition experts to provide education you can trust.
For over 130 years, Abbott has been committed to helping people live their best possible life through the power of health. Abbott’s broad portfolio of science-based nutrition products nourish at every stage of life. Our research is focused on specific health areas, such as the prevention and management of muscle mass loss through specialized nutrition. The Abbott Nutrition Health Institute (ANHI) connects and empowers people through science-based nutrition resources to optimize health worldwide. ANHI presents the latest science by partnering with leading nutrition experts to provide education you can trust.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Visit: www.bd.com
B. Braun is one of the world's leading manufacturers of medical devices and pharmaceutical products and services. Through constructive dialog, B. Braun develops high quality product systems and services that are both evolving and progressive.
Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.
Where other providers merely see products, DSM sees purpose. As a reliable, end-to-end, innovative, purpose-led partner, DSM offers a broad portfolio of science-backed products, customized solutions powered by expert services uniquely aimed at supporting your entire product life cycle, from concept to consumer. This takes more than ingredients; it takes a partner. See how purpose drives everything at PartnerWithDSM.com
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Product portfolio: I.V. generic drugs, infusion therapies and clinical nutrition products as well as the related devices. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies. For more information, visit www.fresenius-kabi.com.
The Swiss family owned company Geistlich Pharma develops and produces pharmaceutical and medical devices since 1851 with a worldwide distribution and provides valuable assistance in solving medical issues. Products such as the antimicrobial catheter lock solution TauroSept® for the prevention and treatment of CRBSIs, originate from the company’s own research facilities in Central Switzerland.
EUROPEAN MILK FORUM
'Milk, Nutritious by Nature' is an information initiative from the European Milk Forum (EMF) addressing science-based issues on dairy and health and engaging in a dialogue with health and nutrition professionals. The aim is to build a clearer understanding of the role of milk and dairy products in a healthy, balanced diet across Europe. EMF is a non-profit organization. The initiative’s objective is to disseminate relevant information and create a dialogue with key stakeholders in relation to the nutrient richness and health impact of milk and dairy products and how those nutrients and other components come together in the dairy matrix to exert their beneficial effects.
Nestlé Health Science is a globally recognized leader in the field of nutritional science, committed to redefining the health management. Offering an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. NHSc is headquartered in Switzerland, with more than 7,000 employees around the world, represented in 160 countries. Half of our business is dedicated to medical nutrition. We believe in empowering healthier lives through nutrition. Our extensive research network, within Nestlé’s R&D centers and external partners, provides the foundation for products that can help people to live their healthiest lives.
Building on 125 years of research, innovation and care, Nutricia pioneers medical nutrition that helps enable life-changing and life-saving health outcomes. The Nutricia portfolio includes a wide range of products that target not only disease-related requirements, but also the changing needs of the body as it ages, to help stay independent and active for longer. Our range includes products in the areas of Frailty & Disease Related Malnutrition, Critical Care & Medical Devices, Oncology, Stroke & Dysphagia as well as early Alzheimer’s Disease.
NZMP is the dairy ingredients and solutions arm for Fonterra. We take our farmer's grass fed milk from New Zealand and create innovative solutions for our customers globally. Our purpose as a Medical Nutrition business is to pioneer nutritional solutions for patients and healthy agers, to help them live longer, healthier lives. Visit our website to see our full breadth of dairy solutions.
TauroPharm GmbH is a German company specialising in medical devices with antimicrobial, antibiofilm and antiocclusive efficacy. Our innovative products effectively prevent catheter-associated complications – ranging from blood clotting to fatal infections, thus improving patients´ quality of life. Since there is an urgent need for our products, especially in light of the steadily increasing number of antibiotics-resistant pathogens, TauroLock is recommended in interdisciplinary national and international guidelines. All products have been investigated in independent scientific studies with excellent study results.
VectivBio is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. The company is committed to pursuing product candidates with a clear mechanism of action and the potential to meaningfully transform and improve the lives of patients and their families. VectivBio’s lead investigational program, apraglutide, is a next-generation, long-acting GLP-2 analog being developed as a differentiated therapeutic for a range of rare gastrointestinal (GI) diseases. Apraglutide is currently being evaluated in a global Phase 3 clinical trial as a once-weekly treatment for short bowel syndrome with intestinal failure (SBS-IF).
Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs.